Therigy Debuts RSV Solution for TherigySTM

Maitland, FL (November 10, 2014) — Therigy today announced the release of a new module, Respiratory Syncytial Virus (RSV), within its specialty therapy management application TherigySTM. Currently, Synagis® is the only FDA-approved drug commercially available in the United States for …

Therigy Launches New Website

Therigy, LLC, is pleased to announce the launch of its newly designed website: www.therigy.com. The new design captures the look and spirit of Therigy’s brand and reflects the company’s position as the specialty pharmaceutical industry’s trusted source for technology, consulting, …

We’ve Moved!

We’re excited to announce we’ve moved to a new office! This relocation comes as a direct result of the year-over-year growth we have experienced in both customers and personnel during the past twelve months. Our new office is located in …

Therigy Wins Florida Company to Watch Award

From more than 600 nominees, Therigy receives the distinction of being named one of the 50 Florida Companies to Watch of 2013. Orlando, Florida – (August 28, 2013) – Therigy, LLC, the trusted source for specialty pharmaceutical consulting, web products, …